FORTY-SEVENTH LEGISLATURESB 23/a

FIRST SESSION, 2005

February 14, 2005

Madam President:

    Your CORPORATIONS AND TRANSPORTATION COMMITTEE, to whom has been referred

SENATE BILL 23

has had it under consideration and reports same with recommendation that it DO PASS, amended as follows:

    1. On page 1, line 24, after the period insert "Differences in copayments are permitted to differentiate between generic drugs and brand-name drugs.".

    2. On page 2, line 9, after the period insert "Differences in copayments are permitted to differentiate between generic drugs and brand-name drugs.".

    3. On page 2, line 19, after the period insert "Differences in copayments are permitted to differentiate between generic drugs and brand-name drugs.".

    4. On page 3, line 4, after the period insert "Differences in copayments are permitted to differentiate between generic drugs and brand-name drugs.".

    5. On page 3, line 14, after the period insert "Differences in copayments are permitted to differentiate between generic drugs and brand-name drugs.".,

and thence referred to the PUBLIC AFFAIRS COMMITTEE.

                               Respectfully submitted,

                               __________________________________

                               SHANNON ROBINSON, Chairman

Adopted_______________________ Not Adopted_______________________

          (Chief Clerk) (Chief Clerk)

                  Date ________________________

The roll call vote was 3 For 2 Against

Yes:      3

No:       Robinson, Snyder

Excused: Boitano, Duran, Ingle, Nava

Absent:   None

SB0023CT1                                              .154900.1